Standout Papers
Citation Impact
Citing Papers
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
The Human SepSecS-tRNA Sec Complex Reveals the Mechanism of Selenocysteine Formation
2009 StandoutScienceNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score
2014
Analysing Recurrent Hospitalizations in Heart Failure: A Review of Statistical Methodology, with Application to CHARM-Preserved
2013
Nano-enabled pesticides for sustainable agriculture and global food security
2022 Standout
Impact of Red Blood Cell Transfusion on Platelet Aggregation and Inflammatory Response in Anemic Coronary and Noncoronary Patients
2013
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
Venographic comparison of subcutaneous low–molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis
1999
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
2016
Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study
2005
New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
2013
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial
2011
Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort
2004
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials
2004
Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies
2011
New P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention
2010
Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials
2011
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
2013
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI
2011
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006
2007
How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials
2005
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Silent Pulmonary Embolism in Patients with Deep Venous Thrombosis: A Systematic Review
2010
Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes
2005
Trends in Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
2005
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
2012
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
2012
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
Nucleotide signalling during inflammation
2014 StandoutNature
Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome
2010
Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
2010
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study 2b/3a upstream therapy and acute coronary syndromes
2003
Variability in Individual Responsiveness to Clopidogrel
2007
Purinergic Signaling in the Airways
2012
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
2012
Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non–ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature
2004
High-resolution crystal structure of human protease-activated receptor 1
2012 StandoutNatureNobel
Climate-smart soils
2016 StandoutNature
New Antithrombotic Drugs
2012
Antithrombotic Therapy for VTE Disease
2016 Standout
Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes
2005
Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction
2006 Standout
Ability of Minor Elevations of Troponins I and T to Predict Benefit From an Early Invasive Strategy in Patients With Unstable Angina and Non-ST Elevation Myocardial Infarction<SUBTITLE>Results From a Randomized Trial</SUBTITLE>
2001
Inflammatory markers according to types of atrial fibrillation
2007
Evolution in Cardiovascular Care for Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
2005
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
2011
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial
2005
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
2011 Standout
Complete nitrification by Nitrospira bacteria
2015 StandoutNature
A Citywide Protocol for Primary PCI in ST-Segment Elevation Myocardial Infarction
2008
Results from the Atherosclerosis Risk in Communities study suggest that low serum magnesium is associated with incident kidney disease
2014
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
2013
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
2012
New Antithrombotic Drugs
2009
Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature
2015
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
2015
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
2013
Managing nitrogen for sustainable development
2015 StandoutNature
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome
2014
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays
2014 StandoutNobel
Early Aggressive Versus Initially Conservative Treatment in Elderly Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
2012
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
Long-Term Outcome of a Routine Versus Selective Invasive Strategy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
2014
Recent Trends in the Care of Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
2006
Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction
2002
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
2015
Optimisation of the anaerobic digestion of agricultural resources
2008 Standout
Comparison of 600 Versus 300-mg Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Coronary Angioplasty
2010
Patterns of Presentation and Outcomes of Patients with Acute Coronary Syndromes
2009
Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization
2004
Ticagrelor
2011
The importance of selenium to human health
2000 Standout
Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
2010
Digoxin and Mortality in Patients With Atrial Fibrillation
2018
Antiplatelet Drugs
2012
Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial
2002
Is early invasive treatment of unstable coronary artery disease equally effective for both women and men?
2001
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
2012
Women with acute coronary syndrome are less invasively examined and subsequently less treated than men
2009
Ticagrelor
2011
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
Comparative Effectiveness of Clopidogrel in Medically Managed Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction
2014
Current concepts on coronary revascularization in diabetic patients
2011
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Unsuspected pulmonary embolism identified using multidetector computed tomography in hospital outpatients
2009
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era
2010
Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
2012
Antithrombotic Therapy in the Elderly
2010
Clopidogrel–Drug Interactions
2011
Association of prior coronary artery bypass graft surgery with quality of care of patients with non–ST-segment elevation myocardial infarction: A report from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines
2010
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society
2009
Antithrombotic Therapy in Atrial Fibrillation
2004
Benefit of Early Invasive Therapy in Acute Coronary Syndromes
2006
Evaluation of Prolonged Antithrombotic Pretreatment ("Cooling-Off" Strategy) Before Intervention in Patients With Unstable Coronary Syndromes
2003
Guidelines for Percutaneous Coronary Interventions
2005
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
2007
The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction
2006
A meta-analysis of anticoagulation for calf deep venous thrombosis
2011
Impaired platelet P2Y12 inhibition by thienopyridines in chronic kidney disease: mechanisms, clinical relevance and pharmacological options
2013
Effect of Study Setting on Anticoagulation Control
2006
Platelet Inhibition with Cangrelor in Patients Undergoing PCI
2009
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients
2009
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non–ST-elevation acute coronary syndromes
2002
Non-adherence to cardiovascular medications
2014
V_alue of First Day Angiography/Angioplasty I_n Evolving N_on-ST Segment Elevation Myocardial Infarction: An O_pen Multicenter Randomized Trial. The VINO Study
2002
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
2006
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
2001
Resolving the Role of Plant Glutamate Dehydrogenase. I. in vivo Real Time Nuclear Magnetic Resonance Spectroscopy Experiments
2009 StandoutNobel
How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?
2010
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
2016
Use of Invasive Strategy in Non–ST-Segment Elevation Myocardial Infarction Is a Major Determinant of Improved Long-Term Survival
2012
A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)
2002
Aspirin Dose for the Prevention of Cardiovascular Disease
2007
New Risk Score for Patients With Acute Chest Pain, Non-ST-Segment Deviation, and Normal Troponin Concentrations
2005
Factors associated with failure to identify the culprit artery by the electrocardiogram in inferior ST-elevation myocardial infarction
2011
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
2012
Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
2008
Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing
2011
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
2013
Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
2011
A longitudinal population‐based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990–1999
2006
Silent pulmonary embolism in patients with distal deep venous thrombosis: Systematic review
2014
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
2010
Will the Universal Definition of Myocardial Infarction Criteria Result in an Overdiagnosis of Myocardial Infarction?
2008
Mortality and Morbidity Reduction by Primary Percutaneous Coronary Intervention Is Independent of the Patient's Age
2010
Early angioplasty in acute coronary syndromes without persistent st-segment elevation improves outcome but increases the need for six-month repeat revascularization
2002
System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention
2010
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions
2008
Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial
2006
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction
2004
Coronary-Artery Stents
2006
The feasibility and safety of routine thrombus aspiration in patients with non‐ST‐elevation myocardial infarction
2008
Stabilisation of atherosclerotic plaques
2011
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
2014
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy
2001
Antithrombotic Therapy for Atrial Fibrillation
2012
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology
2011
Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor
2013
Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes
2013
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
2009
Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes
2006
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset
2016
5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial
2010
Antithrombotic Therapy in Atrial Fibrillation
2008
Complementary prognostic values of ST segment deviation and Thrombolysis In Myocardial Infarction (TIMI) risk score in non-ST elevation acute coronary syndromes: Insights from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study
2009
Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention
2013
Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
2004
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Ammonia in the environment: From ancient times to the present
2008
Rural Interhospital Transfer of ST-Elevation Myocardial Infarction Patients for Percutaneous Coronary Revascularization
2008
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function
2010
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Pretreatment With P2Y 12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome Is Clinically Justified
2014
Transformation of the Nitrogen Cycle: Recent Trends, Questions, and Potential Solutions
2008 StandoutScience
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
2017
Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes
2004
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial
2008
Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial
2014
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Antiplatelet and Anticoagulation Therapy for Acute Coronary Syndromes
2014
Hypercoagulopathy in Stroke Patients with Nonvalvular Atrial Fibrillation: Hematologic and Cardiologic Investigations
2006
Antithrombotic Therapy in Patients With Chronic Kidney Disease
2012
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
Aprotinin Decreases Postoperative Bleeding and Number of Transfusions in Patients on Clopidogrel Undergoing Coronary Artery Bypass Graft Surgery
2005
Methane productivity of manure, straw and solid fractions of manure
2003
Strong control over multiple endpoints: are we adding value to the assessment of medicines?
2013
Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes
2004
Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study.
2004
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
2011
Pretreatment with P2Y 12 Inhibitors in Non–ST-Segment–Elevation Acute Coronary Syndrome: An Outdated and Harmful Strategy
2014
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Biological Degradation and Greenhouse Gas Emissions during Pre‐Storage of Liquid Animal Manure
2004
Incidental Detection of Pulmonary Emboli on Routine MDCT of the Chest
2005
Thrombolysis for acute deep vein thrombosis
2016
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
2009
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
2018
Alternative Methods for Measuring Inorganic, Organic, and Total Dissolved Nitrogen in Soil
2010
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Natural History of Venous Thromboembolism
2003
Perdas do nitrogênio da uréia no sistema solo-planta em dois ciclos de cana-de-açúcar
2002
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
2009
Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract
2005 Standout
The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
2014
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
2010
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina
2003
2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)
2012
2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
2012
¿Mejora el uso de abciximab intracoronario el resultado del intervencionismo percutáneo? Estudio prospectivo y aleatorizado
2006
Minimizing the Risks of Anticoagulants and Platelet Inhibitors
2010
Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study
2016
The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with Non–ST-Segment Elevation Acute Coronary Syndromes
2004
Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease
2003
Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality
2011
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome
2007
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
2011
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Brønsted Acidity in Metal–Organic Frameworks
2015 StandoutNobel
Frailty Is Independently Associated With Short-Term Outcomes for Elderly Patients With Non–ST-Segment Elevation Myocardial Infarction
2011
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Familial Aggregation of Atrial Fibrillation
2009
Stent Thrombosis With Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes
2013
Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
2004
Clinical Implications of Percutaneous Coronary Intervention-Clopidogrel in Unstable angina to prevent Recurrent Events (PCI-CURE) Study
2002
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
2007
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
2010
Investigating the functional link between TMEM165 and SPCA1
2019 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Does Intracoronary Abciximab Improve the Outcome of Percutaneous Coronary Interventions? A Randomized Controlled Trial
2006
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Influence of Renal Function on the Effects of Early Revascularization in Non-ST-Elevation Myocardial Infarction
2009
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
2009
Clopidogrel Response Variability and Future Therapies
2006
Characterization of Mammalian Selenoproteomes
2003 StandoutScience
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome
2004
Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
2011
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.
2013
Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis
2010
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Nitrogen in Agriculture: Balancing the Cost of an Essential Resource
2009
Works of Steen Husted being referenced
The quality of routine oral anticoagulant therapy in a large geographical area. A survey of 310,300 inhabitants.
2002
Abstract 12092: Proton Pump Inhibitor Use is Likely a Marker for, Rather than a Cause of, a Higher Risk of Cardiovascular Events: Insights from PLATO
2010
Better outcome after 2 years with an early invasive strategy in unstable coronary artery disease (UCAD) - FRISCII 2 year follow-up.
2001
Dual Inhibitory Action of ATP on Adrenergic Neuroeffector Transmission in Rabbit Pulmonary Artery
1985
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)
2013
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations inP2RY12, P2RY1,andITGB3
2009
Seasonal Variation in Hospital Discharge Diagnosis of Atrial Fibrillation: A Population-Based Study
2002
Quantitative T-wave analysis predicts 1 year prognosis and benefit from early invasive treatment in the FRISC II study population
2004
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome
2007
The Evolutionarily Conserved Protein PHOTOSYNTHESIS AFFECTED MUTANT71 is Required for Efficient Manganese Uptake at the Thylakoid Membrane in Arabidopsis
2016
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
2006
A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease
2002
Is there a hypercoagulable phase during initiation of antithrombotic therapy with oral anticoagulants in patients with atrial fibrillation?
2003
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
2010
High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
2013
Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel
2010
Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practices
2002
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Acetylsalicylic acid 100 mg and 1000 mg daily in acute myocardial infarction suspects: a placebo‐controlled trial
1989
A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy
2002
Apoplastic pH and Ammonium Concentration in Leaves of Brassica napus L
1995
Haemostatic Activity in Patients with Atrial Fibrillation Treated with Low-Molecular-Weight Heparin Before and After Electrical Cardioversion
2004
Trend in Mortality after Stroke with Atrial Fibrillation
2007
Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy
2014
Incident Thromboembolism in the Aorta and the Renal, Mesenteric, Pelvic, and Extremity Arteries After Discharge From the Hospital With a Diagnosis of Atrial Fibrillation
2001
Trends in Risk of Stroke in Patients with a Hospital Diagnosis of Nonvalvular Atrial Fibrillation: National Cohort Study in Denmark, 1980–2002
2006
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
2010
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
2012
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
2016
Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist
2009
A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction
2003
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
2015
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
2010
Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial
2014
Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
2010
Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation
1994
Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
2009
5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study
2006
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
2011
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
2013
Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome
2009
Anticoagulant therapy in deep venous thrombosis. A randomized controlled study
1994
Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women
2003
Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation
2000
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes
2011
Atrial fibrillation or flutter and stroke: a Danish population‐based study of the effectiveness of oral anticoagulation in clinical practice
2002
Documento de Consenso de Expertos sobre el uso de agentes antiplaquetarios
2004
Antiplatelet agents for the treatment and prevention of atherothrombosis
2011
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
2013
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
2010
Ammonia compensation points in two cultivars of Hordeum vulgare L. during vegetative and generative growth
1996
Physiological parameters controlling plant–atmosphere ammonia exchange
1998
Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization
2013
Fluxes of ammonia over oilseed rape
2000
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
2013
Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes
2007
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies
2010
Seasonal Variation in Methane Emission from Stored Slurry and Solid Manures
1994
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack
2012
Methods to Visualize Elements in Plants
2020
Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial
2000
The chemical buffer system in raw and digested animal slurry
1995
Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study
2013
A critical experimental evaluation of methods for determination of NH4+ in plant tissue, xylem sap and apoplastic fluid
2000
Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
2010
Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis
2010
Influence of nitrogen nutrition and metabolism on ammonia volatilization in plants
1998
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention
2013
High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation
2013
Early Administration of Intravenous Magnesium Inhibits Arterial Thrombus Formation
1997
A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease: two-year follow-up of the FRISC-II invasive study
2003
Resistance modelling of ammonia exchange over oilseed rape
2000